1 Green Flag for Novavax in 2022, and 1 Red Flag
Novavax (NASDAQ: NVAX) is arriving more than a year after market leaders Pfizer and Moderna to the coronavirus vaccine finish line. Novavax soared 2,700% in 2020. As of today, Novavax's vaccine has won authorization from more than 30 countries.